ILMN Illumina Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ILMN

Price (delayed)

$193.81

Market cap

$30.49B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.08

Enterprise value

$31.71B

Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a ...

Highlights
Illumina's revenue has increased by 18% YoY
The company's gross profit rose by 16% YoY
The equity has soared by 102% YoY but it has decreased by 4.1% from the previous quarter
ILMN's net income has dropped by 103% since the previous quarter and by 103% year-on-year
Illumina's EPS has shrunk by 102% QoQ and by 102% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.illumina.com
Peers: PKI PACB A TMO

Key stats

What are the main financial stats of ILMN
Market
Shares outstanding
157.3M
Market cap
$30.49B
Enterprise value
$31.71B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.92
Price to sales (P/S)
6.49
EV/EBIT
660.67
EV/EBITDA
81.94
EV/Sales
6.76
Earnings
Revenue
$4.69B
EBIT
$48M
EBITDA
$387M
Free cash flow
$53M
Per share
EPS
-$0.08
Free cash flow per share
$0.34
Book value per share
$66.48
Revenue per share
$29.89
TBVPS
$32.41
Balance sheet
Total assets
$15.45B
Total liabilities
$5B
Debt
$2.52B
Equity
$10.44B
Working capital
$10M
Liquidity
Debt to equity
0.24
Current ratio
1
Quick ratio
0.68
Net debt/EBITDA
3.17
Margins
EBITDA margin
8.2%
Gross margin
67.5%
Net margin
-0.4%
Operating margin
-19.2%
Efficiency
Return on assets
-0.1%
Return on equity
-0.2%
Return on invested capital
1.1%
Return on capital employed
0.4%
Return on sales
1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ILMN stock price

How has the Illumina stock price performed over time
Intraday
-3.72%
1 week
0.17%
1 month
-7.79%
1 year
-52.91%
YTD
-49.06%
QTD
5.13%

Financial performance

How have Illumina's revenue and profit performed over time
Revenue
$4.69B
Gross profit
$3.17B
Operating income
-$899M
Net income
-$20M
Gross margin
67.5%
Net margin
-0.4%
Illumina's net margin has shrunk by 103% QoQ and by 102% YoY
ILMN's net income has dropped by 103% since the previous quarter and by 103% year-on-year
Illumina's revenue has increased by 18% YoY
The company's gross profit rose by 16% YoY

Growth

What is Illumina's growth rate over time

Valuation

What is Illumina stock price valuation
P/E
N/A
P/B
2.92
P/S
6.49
EV/EBIT
660.67
EV/EBITDA
81.94
EV/Sales
6.76
Illumina's EPS has shrunk by 102% QoQ and by 102% YoY
The equity has soared by 102% YoY but it has decreased by 4.1% from the previous quarter
The price to book (P/B) is 71% lower than the 5-year quarterly average of 10.1 and 39% lower than the last 4 quarters average of 4.8
ILMN's P/S is 52% below its 5-year quarterly average of 13.5 and 43% below its last 4 quarters average of 11.3
Illumina's revenue has increased by 18% YoY

Efficiency

How efficient is Illumina business performance
The ROE has plunged by 103% from the previous quarter and by 101% YoY
The company's return on assets has shrunk by 102% QoQ and by 101% YoY
Illumina's return on sales has shrunk by 96% YoY and by 95% QoQ
ILMN's return on invested capital has dropped by 94% year-on-year and by 94% since the previous quarter

Dividends

What is ILMN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ILMN.

Financial health

How did Illumina financials performed over time
The quick ratio has plunged by 88% YoY and by 50% from the previous quarter
The current ratio has plunged by 84% YoY and by 46% from the previous quarter
Illumina's debt is 76% lower than its equity
The equity has soared by 102% YoY but it has decreased by 4.1% from the previous quarter
The debt to equity is down by 48% year-on-year but it is up by 4.3% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.